Literature DB >> 27454076

Mitigating Prenatal Zika Virus Infection in the Americas.

Martial L Ndeffo-Mbah1, Alyssa S Parpia1, Alison P Galvani1.   

Abstract

BACKGROUND: Because of the risk for Zika virus infection in the Americas and the links between infection and microcephaly, other serious neurologic conditions, and fetal death, health ministries across the region have advised women to delay pregnancy. However, the effectiveness of this policy in reducing prenatal Zika virus infection has yet to be quantified.
OBJECTIVE: To evaluate the effectiveness of pregnancy-delay policies on the incidence and prevalence of prenatal Zika virus infection.
DESIGN: Vector-borne Zika virus transmission model fitted to epidemiologic data from 2015 to 2016 on Zika virus infection in Colombia.
SETTING: Colombia, August 2015 to July 2017. PATIENTS: Population of Colombia, stratified by sex, age, and pregnancy status. INTERVENTION: Recommendations to delay pregnancy by 3, 6, 9, 12, or 24 months, at different levels of adherence. MEASUREMENTS: Weekly and cumulative incidence of prenatal infections and microcephaly cases.
RESULTS: With 50% adherence to recommendations to delay pregnancy by 9 to 24 months, the cumulative incidence of prenatal Zika virus infections is likely to decrease by 17% to 44%, whereas recommendations to delay pregnancy by 6 or fewer months are likely to increase prenatal infections by 2% to 7%. This paradoxical exacerbation of prenatal Zika virus exposure is due to an elevated risk for pregnancies to shift toward the peak of the outbreak. LIMITATION: Sexual transmission was not explicitly accounted for in the model because of limited data but was implicitly subsumed within the overall transmission rate, which was calibrated to observed incidence.
CONCLUSION: Pregnancy delays can have a substantial effect on reducing cases of microcephaly but risks exacerbating the Zika virus outbreak if the duration is not sufficient. Duration of the delay, population adherence, and the timing of initiation of the intervention must be carefully considered. PRIMARY FUNDING SOURCE: National Institutes of Health.

Entities:  

Mesh:

Year:  2016        PMID: 27454076     DOI: 10.7326/M16-0919

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo.

Authors:  Chad R Wells; Abhishek Pandey; Martial L Ndeffo Mbah; Bernard-A Gaüzère; Denis Malvy; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

Review 2.  Quantifying Zika: Advancing the Epidemiology of Zika With Quantitative Models.

Authors:  Lindsay T Keegan; Justin Lessler; Michael A Johansson
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

3.  A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern.

Authors:  Pei-Ying Kobres; Jean-Paul Chretien; Michael A Johansson; Jeffrey J Morgan; Pai-Yei Whung; Harshini Mukundan; Sara Y Del Valle; Brett M Forshey; Talia M Quandelacy; Matthew Biggerstaff; Cecile Viboud; Simon Pollett
Journal:  PLoS Negl Trop Dis       Date:  2019-10-04

Review 4.  Contemporary Understanding of Ebola and Zika Virus in Pregnancy.

Authors:  Lauren Sayres; Brenna L Hughes
Journal:  Clin Perinatol       Date:  2020-10-16       Impact factor: 3.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.